# Hills Bancorporation: financial statements, quarterly

HBIA · OTC · CIK 732417 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hbia.md) · [Financials](/companies/hbia/financials.md) · [Filings](/companies/hbia/filings.md) · [Insiders](/companies/hbia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hbia/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [15.9](/filings/0000732417-23-000039.md) | [18.7 d](/filings/0000732417-24-000009.md) | [21.1](/filings/0000732417-24-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.8](/filings/0000732417-24-000038.md) | [1.9 d](/filings/0000732417-26-000022.md) | [3.1](/filings/0000732417-25-000029.md) | [3.3](/filings/0000732417-25-000038.md) | [3.2](/filings/0000732417-25-000058.md) | [2.9 d](/filings/0000732417-26-000022.md) | [3.3](/filings/0000732417-26-000054.md) | [5.0](/filings/0000732417-26-000070.md) | [3.3](/filings/0000732417-25-000058.md) | [3.6 d](/filings/0000732417-26-000022.md) | [5.6](/filings/0000732417-26-000054.md) | [7.2](/filings/0000732417-26-000070.md) |
| Net income | $m | [7.2](/filings/0000732417-24-000038.md) | [6.9 d](/filings/0000732417-26-000022.md) | [12.1](/filings/0000732417-25-000029.md) | [12.3](/filings/0000732417-25-000038.md) | [12.2](/filings/0000732417-25-000058.md) | [11.0 d](/filings/0000732417-26-000022.md) | [14.4](/filings/0000732417-26-000054.md) | [18.7](/filings/0000732417-26-000070.md) | [12.9](/filings/0000732417-25-000058.md) | [14.5 d](/filings/0000732417-26-000022.md) | [21.9](/filings/0000732417-26-000054.md) | [26.0](/filings/0000732417-26-000070.md) |
| Diluted EPS | $ per share | [0.79](/filings/0000732417-24-000038.md) | not reported | [1.33](/filings/0000732417-25-000029.md) | [1.35](/filings/0000732417-25-000038.md) | [1.35](/filings/0000732417-25-000058.md) | not reported | [1.61](/filings/0000732417-26-000054.md) | [1.05](/filings/0000732417-26-000070.md) | [1.46](/filings/0000732417-25-000058.md) | not reported | [2.50](/filings/0000732417-26-000054.md) | [1.49](/filings/0000732417-26-000070.md) |
| Basic EPS | $ per share | [0.79](/filings/0000732417-24-000038.md) | not reported | [1.33](/filings/0000732417-25-000029.md) | [1.35](/filings/0000732417-25-000038.md) | [1.35](/filings/0000732417-25-000058.md) | not reported | [1.61](/filings/0000732417-26-000054.md) | [1.05](/filings/0000732417-26-000070.md) | [1.46](/filings/0000732417-25-000058.md) | not reported | [2.50](/filings/0000732417-26-000054.md) | [1.49](/filings/0000732417-26-000070.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [110](/filings/0000732417-23-000039.md) | [59.5](/filings/0000732417-25-000015.md) | [94.1](/filings/0000732417-24-000023.md) | [34.2](/filings/0000732417-24-000030.md) | [54.3](/filings/0000732417-24-000038.md) | [123](/filings/0000732417-26-000022.md) | [105](/filings/0000732417-25-000029.md) | [52.5](/filings/0000732417-25-000038.md) | [47.2](/filings/0000732417-25-000058.md) | [42.1](/filings/0000732417-26-000070.md) | [56.1](/filings/0000732417-26-000054.md) | [42.1](/filings/0000732417-26-000070.md) |
| Total assets | $m | [4,246](/filings/0000732417-23-000039.md) | [4,342](/filings/0000732417-25-000015.md) | [4,388](/filings/0000732417-24-000023.md) | [4,342](/filings/0000732417-24-000030.md) | [4,437](/filings/0000732417-24-000038.md) | [4,588](/filings/0000732417-26-000022.md) | [4,564](/filings/0000732417-25-000029.md) | [4,605](/filings/0000732417-25-000038.md) | [4,653](/filings/0000732417-25-000058.md) | [4,648](/filings/0000732417-26-000070.md) | [4,673](/filings/0000732417-26-000054.md) | [4,796](/filings/0000732417-26-000070.md) |
| Total liabilities | $m | [3,756](/filings/0000732417-23-000039.md) | [3,827](/filings/0000732417-25-000015.md) | [3,876](/filings/0000732417-24-000023.md) | [3,820](/filings/0000732417-24-000030.md) | [3,897](/filings/0000732417-24-000038.md) | [4,047](/filings/0000732417-26-000022.md) | [4,020](/filings/0000732417-25-000029.md) | [4,043](/filings/0000732417-25-000038.md) | [4,069](/filings/0000732417-25-000058.md) | [4,045](/filings/0000732417-26-000070.md) | [4,069](/filings/0000732417-26-000054.md) | [4,167](/filings/0000732417-26-000070.md) |
| Short-term borrowings | $m | not reported | [219](/filings/0000732417-25-000015.md) | not reported | [376](/filings/0000732417-24-000030.md) | [323](/filings/0000732417-24-000038.md) | [547](/filings/0000732417-26-000022.md) | [0.0](/filings/0000732417-25-000029.md) | [391](/filings/0000732417-25-000038.md) | [589](/filings/0000732417-25-000058.md) | [587](/filings/0000732417-26-000070.md) | [380](/filings/0000732417-26-000054.md) | [297](/filings/0000732417-26-000070.md) |
| Shareholders' equity | $m | [445](/filings/0000732417-24-000038.md) | [470](/filings/0000732417-26-000022.md) | [465](/filings/0000732417-25-000038.md) | [476](/filings/0000732417-25-000058.md) | [494](/filings/0000732417-25-000058.md) | [493](/filings/0000732417-26-000070.md) | [494](/filings/0000732417-26-000070.md) | [511](/filings/0000732417-26-000070.md) | [531](/filings/0000732417-25-000058.md) | [548](/filings/0000732417-26-000070.md) | [546](/filings/0000732417-26-000070.md) | [569](/filings/0000732417-26-000070.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.2 d](/filings/0000732417-24-000038.md) | [12.3 d](/filings/0000732417-26-000022.md) | [13.2](/filings/0000732417-25-000029.md) | [5.9 d](/filings/0000732417-25-000038.md) | [25.2 d](/filings/0000732417-25-000058.md) | [11.2 d](/filings/0000732417-26-000022.md) | [15.0](/filings/0000732417-26-000054.md) | [8.5 d](/filings/0000732417-26-000070.md) | [22.7 d](/filings/0000732417-25-000058.md) | [22.6 d](/filings/0000732417-26-000022.md) | [21.2](/filings/0000732417-26-000054.md) | [22.0 d](/filings/0000732417-26-000070.md) |
| Capital expenditure | $m | [1.1 d](/filings/0000732417-24-000038.md) | [0.7 d](/filings/0000732417-26-000022.md) | [0.3](/filings/0000732417-25-000029.md) | [1.4 d](/filings/0000732417-25-000038.md) | [1.3 d](/filings/0000732417-25-000058.md) | [1.6 d](/filings/0000732417-26-000022.md) | [0.5](/filings/0000732417-26-000054.md) | [0.8 d](/filings/0000732417-26-000070.md) | [0.7 d](/filings/0000732417-25-000058.md) | [1.8 d](/filings/0000732417-26-000022.md) | [0.6](/filings/0000732417-26-000054.md) | [0.3 d](/filings/0000732417-26-000070.md) |
| Dividends paid | $m | [0.0 d](/filings/0000732417-24-000038.md) | [0.0 d](/filings/0000732417-26-000022.md) | [10.1](/filings/0000732417-25-000029.md) | [(0.0) d](/filings/0000732417-25-000038.md) | [0.0 d](/filings/0000732417-25-000058.md) | [0.0 d](/filings/0000732417-26-000022.md) | [10.3](/filings/0000732417-26-000054.md) | [0.0 d](/filings/0000732417-26-000070.md) | [0.0 d](/filings/0000732417-25-000058.md) | [0.0 d](/filings/0000732417-26-000022.md) | [10.8](/filings/0000732417-26-000054.md) | [0.0 d](/filings/0000732417-26-000070.md) |
| Share repurchases | $m | [1.8 d](/filings/0000732417-24-000038.md) | [1.6 d](/filings/0000732417-26-000022.md) | [3.2](/filings/0000732417-25-000029.md) | [2.0 d](/filings/0000732417-25-000038.md) | [6.0 d](/filings/0000732417-25-000058.md) | [1.8 d](/filings/0000732417-26-000022.md) | [2.4](/filings/0000732417-26-000054.md) | [5.1 d](/filings/0000732417-26-000070.md) | [3.6 d](/filings/0000732417-25-000058.md) | [4.5 d](/filings/0000732417-26-000022.md) | [3.1](/filings/0000732417-26-000054.md) | [1.4 d](/filings/0000732417-26-000070.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.3](/filings/0000732417-23-000039.md) | [9.2](/filings/0000732417-24-000023.md) | [9.2](/filings/0000732417-24-000030.md) | [9.2](/filings/0000732417-24-000038.md) | [9.1](/filings/0000732417-25-000029.md) | [9.1](/filings/0000732417-25-000038.md) | [9.0](/filings/0000732417-25-000058.md) | [9.0](/filings/0000732417-26-000054.md) | [17.8](/filings/0000732417-26-000070.md) | [8.9](/filings/0000732417-25-000058.md) | [8.8](/filings/0000732417-26-000054.md) | [17.5](/filings/0000732417-26-000070.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,436,739 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000732417-26-000070.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.